Hennessy Emily A, Bergman Brandon G, Levine Leonard, O'Connor Jenny, Klein Morgan, Kelly John F
Harvard Medical School, Recovery Research Institute Boston Massachusetts USA.
Francis A. Countway Library, Harvard Medical School Boston Massachusetts USA.
Campbell Syst Rev. 2025 Mar 4;21(1):e70021. doi: 10.1002/cl2.70021. eCollection 2025 Mar.
This is the protocol for a Campbell systematic review. The objectives are as follows: (1) What kinds of mutual-help organizations for drug use disorders have been studied with evidence available in the empirical literature? (2) What is the nature of the evidence with regard to the different types of mutual-help organizations?-(a) To what extent are these entities shown to help initiate, sustain, and enhance rates of remission from drug use disorders and improve other functional outcomes when the available evidence is subjected to rigorous scientific scrutiny? (b) To what extent do different mutual-help organizations confer differential benefit and to whom, how, and over what period? (c) To what extent have cost benefit or cost effectiveness studies indicated that these entities are cost-effective?
这是一项坎贝尔系统评价的方案。目标如下：（1）实证文献中有哪些关于药物使用障碍互助组织的研究证据？（2）不同类型互助组织的证据性质是什么？-（a）当现有证据经过严格科学审查时，这些实体在多大程度上有助于启动、维持和提高药物使用障碍的缓解率，并改善其他功能结果？（b）不同的互助组织在多大程度上产生不同的益处，对谁、如何以及在多长时间内产生益处？（c）成本效益或成本效果研究在多大程度上表明这些实体具有成本效益？
